Bi-Partisan House Bills Re-Introduced to Regulate Hemp-Derived CBD
Last week, Reps. Morgan Griffith (R-VA) and Angie Craig (D-MN)
re-introduced
two bills that would require the U.S. Food and Drug Administration (FDA) to regulate hemp-derived cannabidiol (CBD). The first bill, the
Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023
-
H.R.1629
- would subject hemp extract products to the regulatory framework for dietary supplements; while the second bill, the
CBD Product Safety and Standardization Act of 2023
-
H.R.1628
- would establish regulations for CBD as a food and beverage additive. The bills’ introductions follow on the heels of the FDA’s recent announcement asking Congress to work with the agency to develop a regulatory framework for CBD. Read more
here.